Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 May;55(5):517–519. doi: 10.1038/bjc.1987.105

Comparative effects of vinca alkaloids (VCR, VDS) and epipodophyllotoxin (VP16) on murine myeloblastic leukaemia.

Y Yamashita, N Nara, I Murohashi, Y Imai, N Aoki
PMCID: PMC2001737  PMID: 3475108

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barlogie B., Smith L., Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med. 1984 May 24;310(21):1353–1356. doi: 10.1056/NEJM198405243102104. [DOI] [PubMed] [Google Scholar]
  2. Buick R. N., Chang L. J., Messner H. A., Curtis J. E., McCulloch E. A. Self-renewal capacity of leukemic blast progenitor cells. Cancer Res. 1981 Nov;41(11 Pt 2):4849–4852. [PubMed] [Google Scholar]
  3. Buick R. N., Messner H. A., Till J. E., McCulloch E. A. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man. J Natl Cancer Inst. 1979 Feb;62(2):249–255. [PubMed] [Google Scholar]
  4. Hayata I., Seki M., Yoshida K., Hirashima K., Sado T., Yamagiwa J., Ishihara T. Chromosomal aberrations observed in 52 mouse myeloid leukemias. Cancer Res. 1983 Jan;43(1):367–373. [PubMed] [Google Scholar]
  5. Klimo P., Connors J. M. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med. 1985 May;102(5):596–602. doi: 10.7326/0003-4819-102-5-596. [DOI] [PubMed] [Google Scholar]
  6. McCulloch E. A., Buick R. N., Curtis J. E., Messner H. A., Senn J. S. The heritable nature of clonal characteristics in acute myeloblastic leukemia. Blood. 1981 Jul;58(1):105–109. [PubMed] [Google Scholar]
  7. Nara N., Curtis J. E., Senn J. S., Tritchler D. L., McCulloch E. A. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. Blood. 1986 Mar;67(3):762–769. [PubMed] [Google Scholar]
  8. Nara N., Jinnai I., Imai Y., Bessho M., Hirashima K. Reduction of granulocyte-macrophage progenitor cells (CFU-C) and fibroblastoid colony-forming units (CFU-F) by leukemic cells in human and murine leukemia. Acta Haematol. 1984;72(3):171–180. doi: 10.1159/000206383. [DOI] [PubMed] [Google Scholar]
  9. Sauter C., Fehr J., Frick P., Gmuer J., Honegger H., Martz G. Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V). Eur J Cancer Clin Oncol. 1982 Aug;18(8):733–737. doi: 10.1016/0277-5379(82)90071-2. [DOI] [PubMed] [Google Scholar]
  10. Smith S. D., Trueworthy R. C., Kisker S. E., Noller L. G., Lowman J. T. In vitro sensitivity of normal granulocytic and lymphoma colonies to vinca alkaloids. Cancer. 1983 Feb 1;51(3):417–422. doi: 10.1002/1097-0142(19830201)51:3<417::aid-cncr2820510310>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  11. Worton R. G., McCulloch E. A., Till J. E. Physical separation of hemopoietic stem cells from cells forming colonies in culture. J Cell Physiol. 1969 Oct;74(2):171–182. doi: 10.1002/jcp.1040740209. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES